Stock Events

Stock Events

Scorpius 

$0.001000
91
-$0.00-0% Tuesday 20:00

Statistics

Day High
0.0111
Day Low
0.01
52W High
0.1
52W Low
0.0001
Volume
60,814
Avg. Volume
5,602
Mkt Cap
61,143
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

27MayExpected
Q1 2024
Q2 2024
Q3 2024
Q1 2025
Q2 2025
Q4 2025
Q1 2026
-32
-5.54
20.91
47.37
Expected EPS
N/A
Actual EPS
N/A

Financials

-525.52%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
6.24MRevenue
-32.81MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SCPX. It's not an investment recommendation.
NVIDIA
4
NVDA
Microsoft
3
MSFT
AGNC Investment
3
AGNC
Main Street Capital
3
MAIN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap25.28B
Moderna is a leader in mRNA technology, directly competing with Nighthawk Biosciences in the development of innovative vaccines and therapies.
BioNTech
BNTX
Mkt Cap23.38B
BioNTech competes in the mRNA space, similar to Nighthawk Biosciences, focusing on personalized immunotherapies and vaccines.
Novavax
NVAX
Mkt Cap1.33B
Novavax is a competitor in the vaccine development space, particularly for infectious diseases, which aligns with Nighthawk Biosciences' focus areas.
Pfizer
PFE
Mkt Cap152.69B
Pfizer is a large pharmaceutical company with a broad portfolio that includes vaccines and biopharmaceuticals, competing across several of Nighthawk Biosciences' interest areas.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the development of vaccines and therapeutics, overlapping with Nighthawk Biosciences' research and development.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences is involved in the development of antiviral drugs, directly competing with Nighthawk Biosciences in the area of infectious disease treatment.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals competes in the biotechnology space, focusing on monoclonal antibodies, a technology that could be in direct competition with Nighthawk Biosciences' therapeutic approaches.
Vertex Pharmaceuticals
VRTX
Mkt Cap128.19B
Vertex Pharmaceuticals is involved in creating novel therapies for treating serious diseases, potentially competing with Nighthawk Biosciences in the biotech innovation space.
AMGEN
AMGN
Mkt Cap224.63B
Amgen is a biotechnology company focused on human therapeutics, competing with Nighthawk Biosciences in the development of treatments for various diseases.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Nighthawk Biosciences in areas such as oncology, cardiovascular, renal & metabolism, and respiratory diseases.

About

Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company serves the biotechnology and biopharmaceutical industries. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas.
Show more...
CEO
Jeff A. Wolf
Employees
91
Country
United States
ISIN
US42237K5083
WKN
000A40ZHY

Listings

MU
DE
1HB1.MU
STU
DE
1HB.STU
OTC Link
US
SCPX

0 Comments

Share your thoughts

FAQ

What is Scorpius stock price today?▼
The current price of SCPX is $0.00 USD — it has decreased by -0% in the past 24 hours. Watch Scorpius stock price performance more closely on the chart.
What is Scorpius stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Scorpius stocks are traded under the ticker SCPX.
Is Scorpius stock price growing?▼
SCPX stock has fallen by -0% compared to the previous week, the month change is a -16.67% fall, over the last year Scorpius has showed a -90.91% decrease.
What is Scorpius market cap?▼
Today Scorpius has the market capitalization of 61,143
What is Scorpius revenue for the last year?▼
Scorpius revenue for the last year amounts to 6.24M USD.
What is Scorpius net income for the last year?▼
SCPX net income for the last year is -32.81M USD.
How many employees does Scorpius have?▼
As of August 20, 2026, the company has 91 employees.
In which sector is Scorpius located?▼
Scorpius operates in the Health & Wellness sector.
When did Scorpius complete a stock split?▼
The last stock split for Scorpius was on July 18, 2024 with a ratio of 1:200.
Where is Scorpius headquartered?▼
Scorpius is headquartered in San Antonio, United States.